pentoxifylline has been researched along with Cerebrovascular Disorders in 45 studies
Cerebrovascular Disorders: A spectrum of pathological conditions of impaired blood flow in the brain. They can involve vessels (ARTERIES or VEINS) in the CEREBRUM, the CEREBELLUM, and the BRAIN STEM. Major categories include INTRACRANIAL ARTERIOVENOUS MALFORMATIONS; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; and others.
| Excerpt | Relevance | Reference |
|---|---|---|
| " It covers firstly the general problems of stroke, dementia and 'common symptoms' of the elderly, and then looks in detail at those compounds which have to date attracted most attention (ergot derivatives, cinnarizine, flunarizine, vincamine, eburnamonine, naftidrofuryl, oxpentifylline, piracetam and citicoline), as well as those which are currently considered investigational (choline and lecithin)." | 6.15 | 'Cerebroactive' drugs. Clinical pharmacology and therapeutic role in cerebrovascular disorders. ( Spagnoli, A; Tognoni, G, 1983) |
| "Cilostazol has been associated with spontaneous reports of cardiovascular adverse events and serious bleeding." | 3.88 | Safety of cilostazol in peripheral artery disease: a cohort from a primary healthcare electronic database. ( Alzamora, M; Forés, R; Giner-Soriano, M; Heras, A; Marsal, JR; Morros, R; Pera, G; Real, J; Ribes, E; Serna, MC, 2018) |
| "Patients who have had a recent transient ischemic attack (TIA) are at high risk for subsequent stroke." | 3.77 | Epidemiology of and stroke-preventive strategies for atherothromboembolic brain infarction in the elderly. ( Adams, HP; Gordon, DL, 1991) |
| "Pentoxifylline was administered intravenously in a dose of 600 mg daily for 5 days, together with oral aspirin 150 mg daily." | 2.67 | Pentoxifylline in the treatment of acute ischaemic stroke--a reappraisal in Chinese stroke patients. ( Chan, YW; Kay, CS, 1993) |
| " Treatment lasted 7 to 8 weeks with a dosage of 1 tablet 3 times a day." | 2.64 | [Treatment of chronic arterial circulatory disorders. Double blind trial with Trental 400 (author's transl)]. ( Kellner, H, 1976) |
| "Pentoxifylline is a drug known to increase red cell deformability, thus allowing the 7- to 8-micrometers diameter red cell to flow through the narrowest capillaries of 3-5 micrometers diameter." | 2.36 | Pentoxifylline and cerebrovascular diseases. ( George, C; Marcel, GA, 1983) |
| "Musical hallucinations are a kind of auditory hallucination that are prevalent among the non-psychiatric population, but which have rarely been reported in the neurological literature." | 1.40 | [Musical hallucinations: perpetual music]. ( Zabalza-Estévez, RJ, 2014) |
| "Thus, ischemic cerebral edema appears to contribute heavily to morbidity and mortality in stroke." | 1.26 | Cerebral edema in stroke: a common, often fatal complication. ( Easton, JD; Sherman, DG, 1980) |
| "Pentoxifylline was administered orally at a dose of 1200 mg/day over a period of 30 days (eight patients) or by intravenous infusion of 100 ml saline containing 400 mg of the drug in 1 hour (three patients)." | 1.26 | Effect of pentoxifylline on cerebral blood flow in patients with chronic cerebrovascular disease. ( Battistini, N; Nardini, M; Passero, S, 1981) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 33 (73.33) | 18.7374 |
| 1990's | 10 (22.22) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (4.44) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Real, J | 1 |
| Serna, MC | 1 |
| Giner-Soriano, M | 1 |
| Forés, R | 1 |
| Pera, G | 1 |
| Ribes, E | 1 |
| Alzamora, M | 1 |
| Marsal, JR | 1 |
| Heras, A | 1 |
| Morros, R | 1 |
| Zabalza-Estévez, RJ | 1 |
| Agostoni, A | 1 |
| Martin, P | 1 |
| Vives, P | 1 |
| Spagnoli, A | 1 |
| Tognoni, G | 1 |
| Hartmann, A | 4 |
| Beyreder, J | 1 |
| Lechner, H | 4 |
| Ott, E | 5 |
| Bertha, G | 1 |
| Marcel, GA | 1 |
| George, C | 1 |
| Sherman, DG | 1 |
| Easton, JD | 1 |
| Fazekas, F | 1 |
| Emeriau, JP | 1 |
| Deguilhem, M | 1 |
| Borde, C | 1 |
| Raynal, F | 1 |
| Manciet, G | 1 |
| Lorient, MF | 1 |
| Boisseau, MR | 1 |
| Galley, P | 1 |
| Müller, R | 2 |
| Lehrach, F | 2 |
| Shtok, VN | 1 |
| Fedorova, NV | 1 |
| Gadanova, IV | 1 |
| Passero, S | 1 |
| Nardini, M | 1 |
| Battistini, N | 1 |
| Chan, YW | 1 |
| Kay, CS | 1 |
| Gara, II | 1 |
| Frampton, JE | 1 |
| Brogden, RN | 1 |
| Drozdov, SA | 1 |
| Harwart, D | 1 |
| Ueda, N | 1 |
| Muteki, T | 1 |
| Tajiri, M | 1 |
| Tayama, F | 1 |
| Tsutsumi, Y | 1 |
| Watanabe, H | 1 |
| Sakanashi, K | 1 |
| Yoshitake, K | 1 |
| Tessitore, A | 1 |
| Barone, A | 1 |
| Kellner, H | 1 |
| Koppenhagen, K | 1 |
| Wenig, HG | 1 |
| Müller, K | 1 |
| Theis, H | 1 |
| Sen, S | 1 |
| Chakravarty, A | 1 |
| Ritzmann, D | 1 |
| Blume, J | 1 |
| Rùhlmann, KU | 1 |
| de la Haye, R | 1 |
| Rettig, K | 1 |
| Yamamoto, N | 1 |
| Yokota, K | 1 |
| Ikegami, A | 1 |
| Yamashita, A | 1 |
| Ito, K | 1 |
| Szobor, A | 1 |
| Klein, M | 1 |
| Adams, HP | 1 |
| Gordon, DL | 1 |
| Lebedeva, NV | 2 |
| Khrapova, EV | 2 |
| Chandra, B | 1 |
| Bowton, DL | 1 |
| Stump, DA | 1 |
| Prough, DS | 1 |
| Toole, JF | 1 |
| Lefkowitz, DS | 1 |
| Coker, L | 1 |
| Dragunow, M | 1 |
| Schneider, R | 1 |
| Nazarova, KhI | 1 |
| Hsu, CY | 1 |
| Norris, JW | 1 |
| Hogan, EL | 1 |
| Bladin, P | 1 |
| Dinsdale, HB | 1 |
| Yatsu, FM | 1 |
| Earnest, MP | 1 |
| Scheinberg, P | 1 |
| Caplan, LR | 1 |
| Karp, HR | 1 |
| Tsuda, Y | 1 |
| Berdichevskiĭ, MIa | 1 |
| Onopchenko, NV | 1 |
| Dronnikova, IS | 1 |
| Eninia, GI | 1 |
| Egere, DA | 1 |
| Robule, VKh | 1 |
| Maĭore, IKh | 1 |
7 reviews available for pentoxifylline and Cerebrovascular Disorders
| Article | Year |
|---|---|
'Cerebroactive' drugs. Clinical pharmacology and therapeutic role in cerebrovascular disorders.
Topics: Adult; Aged; Cerebrovascular Disorders; Cinnarizine; Clinical Trials as Topic; Cytidine Diphosphate | 1983 |
Therapeutical aspects of cerebrovascular disease.
Topics: Aspirin; Blood Coagulation; Cerebrovascular Disorders; Clofibrate; Dipyridamole; Erythrocyte Aggrega | 1983 |
Pentoxifylline and cerebrovascular diseases.
Topics: Animals; Blood Viscosity; Brain Edema; Cerebrovascular Circulation; Cerebrovascular Disorders; Dogs; | 1983 |
Haemorheology and cerebrovascular disease: multifunctional approach with pentoxifylline.
Topics: Cerebrovascular Circulation; Cerebrovascular Disorders; Edema; Humans; Oxygen Consumption; Pentoxify | 1981 |
Pentoxifylline (oxpentifylline). A review of its therapeutic efficacy in the management of peripheral vascular and cerebrovascular disorders.
Topics: Aged; Cerebrovascular Disorders; Clinical Trials as Topic; Humans; Pentoxifylline; Peripheral Vascul | 1995 |
[Pentoxifylline in the treatment of disorders of the cerebral circulation].
Topics: Cerebrovascular Disorders; Humans; Pentoxifylline; Vasodilator Agents | 1997 |
Epidemiology of and stroke-preventive strategies for atherothromboembolic brain infarction in the elderly.
Topics: Aged; Anticoagulants; Arteriosclerosis; Aspirin; Cerebral Infarction; Cerebrovascular Disorders; Fem | 1991 |
14 trials available for pentoxifylline and Cerebrovascular Disorders
| Article | Year |
|---|---|
'Cerebroactive' drugs. Clinical pharmacology and therapeutic role in cerebrovascular disorders.
Topics: Adult; Aged; Cerebrovascular Disorders; Cinnarizine; Clinical Trials as Topic; Cytidine Diphosphate | 1983 |
Effect of pentoxifylline on regional cerebral blood flow in patients with cerebral vascular disorders.
Topics: Cerebrovascular Circulation; Cerebrovascular Disorders; Clinical Trials as Topic; Humans; Pentoxifyl | 1983 |
Use of pentoxifylline in the treatment of acute cerebrovascular insufficiency.
Topics: Acute Disease; Benzamides; Cerebrovascular Disorders; Clinical Trials as Topic; Drug Therapy, Combin | 1983 |
Effect of pentoxifylline on regional cerebral blood flow in patients with cerebrovascular disease.
Topics: Aged; Cerebrovascular Circulation; Cerebrovascular Disorders; Female; Humans; Male; Middle Aged; Pen | 1981 |
Pentoxifylline in the treatment of acute ischaemic stroke--a reappraisal in Chinese stroke patients.
Topics: Acute Disease; Aged; Asian People; Brain Ischemia; Cerebrovascular Disorders; China; Double-Blind Me | 1993 |
The treatment of chronic cerebrovascular insufficiency. A double-blind study with pentoxifylline ('Trental' 400).
Topics: Administration, Oral; Aged; Cerebrovascular Disorders; Chronic Disease; Clinical Trials as Topic; Do | 1979 |
[Treatment of chronic arterial circulatory disorders. Double blind trial with Trental 400 (author's transl)].
Topics: Administration, Oral; Adult; Aged; Arterial Occlusive Diseases; Cerebrovascular Disorders; Clinical | 1976 |
Clinical experience with pentoxifylline in occlusive cerebrovascular disorders.
Topics: Adult; Cerebrovascular Disorders; Female; Hemiplegia; Humans; Ischemic Attack, Transient; Male; Moto | 1977 |
Treatment of chronic cerebrovascular disease in elderly patients with pentoxifylline.
Topics: Aged; Cerebrovascular Disorders; Chronic Disease; Double-Blind Method; Female; Humans; Male; Middle | 1992 |
Examinations of the relative fluidity in cerebrovascular disease patients.
Topics: Adult; Blood Viscosity; Cerebrovascular Disorders; Ergot Alkaloids; Erythrocyte Indices; Female; Hem | 1992 |
Epidemiology of and stroke-preventive strategies for atherothromboembolic brain infarction in the elderly.
Topics: Aged; Anticoagulants; Arteriosclerosis; Aspirin; Cerebral Infarction; Cerebrovascular Disorders; Fem | 1991 |
[Use of sermion, Cavinton and trental in patients with cerebrovascular disorders].
Topics: Administration, Oral; Adult; Aged; Cerebrovascular Circulation; Cerebrovascular Disorders; Clinical | 1990 |
Pentoxifylline in acute nonhemorrhagic stroke. A randomized, placebo-controlled double-blind trial.
Topics: Acute Disease; Adult; Cerebrovascular Disorders; Clinical Trials as Topic; Double-Blind Method; Huma | 1988 |
A controlled study on the effect of pentoxifylline and an ergot alkaloid derivative on regional cerebral blood flow in patients with chronic cerebrovascular disease.
Topics: Cerebrovascular Circulation; Cerebrovascular Disorders; Chronic Disease; Clinical Trials as Topic; E | 1988 |
26 other studies available for pentoxifylline and Cerebrovascular Disorders
| Article | Year |
|---|---|
Safety of cilostazol in peripheral artery disease: a cohort from a primary healthcare electronic database.
Topics: Age Factors; Aged; Aged, 80 and over; Cardiovascular Agents; Cerebrovascular Disorders; Cilostazol; | 2018 |
[Musical hallucinations: perpetual music].
Topics: Aged; Aged, 80 and over; Causality; Cerebrovascular Disorders; Diagnosis, Differential; Female; Hall | 2014 |
[Current status of medical treatment].
Topics: Aminophylline; Animals; Anticoagulants; Aspirin; Barbiturates; Brain Ischemia; Cerebrovascular Disor | 1980 |
The effect of pentoxifylline on red cell deformability in cerebrovascular accidents.
Topics: Adrenocorticotropic Hormone; Adult; Aged; Capillary Permeability; Cerebrovascular Disorders; Drug Th | 1980 |
Cerebral edema in stroke: a common, often fatal complication.
Topics: Adrenal Cortex Hormones; Antioxidants; Barbiturates; Brain Edema; Cerebral Infarction; Cerebrovascul | 1980 |
Hemorheological effects of pentoxifylline on disturbed flow behavior of blood in patients with cerebrovascular insufficiency.
Topics: Adenosine Diphosphate; Blood Viscosity; Cerebrovascular Disorders; Epinephrine; Erythrocytes; Female | 1983 |
Filterability and cerebro-vascular disease.
Topics: Aged; Blood Flow Velocity; Cerebrovascular Disorders; Erythrocyte Membrane; Erythrocytes; Female; Hu | 1981 |
[Clinical study of the cerebrovascular action of pentoxifylline].
Topics: Acute Disease; Adult; Arteriosclerosis; Brain Ischemia; Cerebrovascular Disorders; Chronic Disease; | 1982 |
Special therapeutical aspects of cerebrovascular disease.
Topics: Aspirin; Cerebrovascular Disorders; Drug Combinations; Female; Humans; Male; Pentoxifylline; Platele | 1981 |
Hemorheologic conditions in patients with cerebrovascular disease altered by treatment with pentoxifylline.
Topics: Blood Viscosity; Cerebrovascular Disorders; Drug Evaluation; Female; Fibrinogen; Hematocrit; Humans; | 1981 |
Effect of pentoxifylline on cerebral blood flow in patients with chronic cerebrovascular disease.
Topics: Aged; Cerebrovascular Circulation; Cerebrovascular Disorders; Chronic Disease; Female; Humans; Male; | 1981 |
[The effect of pentoxifylline and nicergoline on the systemic and cerebral hemodynamics and on the blood rheological properties in patients with an ischemic stroke and atherosclerotic lesions of the major cerebral arteries].
Topics: Acute Disease; Adult; Aged; Blood Flow Velocity; Blood Viscosity; Brain Ischemia; Cerebrovascular Di | 1993 |
Clinical evaluation of the effect of pentoxifylline on circulatory behavior of the brain.
Topics: Adult; Aged; Cerebrovascular Circulation; Cerebrovascular Disorders; Female; Humans; Male; Middle Ag | 1979 |
[Combination of phosphatidylcholine and pentoxifylline in the therapy of progressive obstructive stroke].
Topics: Aged; Blood Viscosity; Cerebrovascular Disorders; Drug Therapy, Combination; Female; Humans; Male; P | 1979 |
Measurement of cerebral blood flow following intravenous administration of pentoxifyline ('Trentral').
Topics: Aged; Cerebrovascular Circulation; Cerebrovascular Disorders; Female; Humans; Injections, Intravenou | 1977 |
[5 years of clinico-experimental and therapeutic experiences with pentoxifylline].
Topics: Arterial Occlusive Diseases; Cerebrovascular Disorders; Chemical Phenomena; Chemistry; Eye Diseases; | 1977 |
[Treatment of cerebrovascular insufficiency symptoms. Experience from practice].
Topics: Adult; Aged; Cerebrovascular Disorders; Drug Combinations; Female; Humans; Male; Middle Aged; Neurol | 1976 |
[Hemorheological effect of KB-2796, a new Ca2+ antagonist].
Topics: Animals; Blood Viscosity; Calcium Channel Blockers; Cerebrovascular Disorders; Erythrocyte Deformabi | 1992 |
Pentoxifylline alters the natural course of acute nonhemorrhagic stroke.
Topics: Acute Disease; Cerebrovascular Disorders; Humans; Nervous System; Pentoxifylline; Theobromine | 1990 |
Pentoxifylline increases cerebral blood flow in patients with cerebrovascular disease.
Topics: Aged; Carbon Dioxide; Cerebrovascular Circulation; Cerebrovascular Disorders; Dose-Response Relation | 1989 |
Possible complications of pentoxifylline in stroke.
Topics: Animals; Cerebrovascular Disorders; Humans; Pentoxifylline; Receptors, Purinergic; Theobromine | 1989 |
[Dynamics of blood serotonin contents in acute disorders of cerebral circulation and circulatory encephalopathy].
Topics: Adult; Aged; Aged, 80 and over; Brain Diseases; Cerebrovascular Disorders; Female; Humans; Hypertens | 1989 |
Results of hemorheologically active treatment with pentoxifylline in patients with cerebrovascular disease.
Topics: Blood Pressure; Blood Viscosity; Cerebrovascular Disorders; Erythrocyte Aggregation; Erythrocyte Def | 1989 |
[Effect of the long-term prophylactic use of trental on cerebral blood flow in diabetics].
Topics: Adult; Cerebrovascular Disorders; Chronic Disease; Diabetes Complications; Diabetes Mellitus; Diabet | 1988 |
[Effect of a series of vasoactive drugs on the compensatory adaptive processes of the brain during acute experimental cerebral venous stasis].
Topics: Adaptation, Physiological; Aminophylline; Animals; Brain; Cerebrovascular Disorders; Hydroxyethylrut | 1987 |
[Indications for using trental in the initial manifestations of inadequate blood supply to the brain].
Topics: Adult; Blood Coagulation; Blood Viscosity; Cerebrovascular Circulation; Cerebrovascular Disorders; F | 1986 |